MIG Capital
MIG Capital AG is a Munich-based venture capital firm founded in 2004 that invests early-to-mid-stage capital from 18 publicly offered MIG Fonds into Deep Tech and Life Sciences startups across Europe, serving both portfolio companies and retail limited partners.
- Company typePrivate
- Founded2004
- HeadquartersMünchen, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What MIG Capital does
MIG Capital AG is a Munich-based venture capital firm founded in 2004 that invests in early to mid-stage Deep Tech and Life Sciences companies primarily across Europe. The firm operates through MIG Fonds, a series of 18 publicly offered retail-VC funds (MIG Fonds 2 through 18) that are 100% subscribed by private investors in Germany and Austria — making MIG the only retail-accessible VC platform of its kind in Germany under KAGB regulation. MIG Capital deploys €1-10 million per deal (with a €3-5 million sweet spot) from seed through Series A, targeting deep tech themes (advanced computing, quantum, IoT, energy, new materials) and life sciences (biopharmaceuticals, medical devices, digital health).
The firm is not a technology developer; its product is capital plus active portfolio support, strategic guidance, and network access delivered through an interdisciplinary team of engineers, biologists, physicists, lawyers, and investors. Its revenue model is conventional for VC: recurring management fees on ~€1.3 billion of committed capital, supplemented by episodic carried interest from exits. To date, MIG Capital has backed 57 companies, holds 32 active positions, and has realized 25 trade-sale exits and 4 IPOs (BioNTech, BRAIN, NFON, Immatics), with BioNTech alone distributing ~€600 million to fund investors.
Recent portfolio activity demonstrates continued diversification into space traffic management (Look Up), AI photonic semiconductors (NcodiN), industrial solar thermal (GlassPoint), and biotech (SciRhom, TIBEAY, iOmx, mbiomics), alongside exits in 2025 including biocrates to Bruker, wealthpilot, creativeballoons, and the insolvency of German Bionic.
MIG Capital firmographics
Firmographics- Name
- MIG Capital
- Legal name
- MIG Capital AG
- Website
- https://mig.ag
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MIG Capital AG is a Munich-based venture capital firm founded in 2004 that invests early-to-mid-stage capital from 18 publicly offered MIG Fonds into Deep Tech and Life Sciences startups across Europe, serving both portfolio companies and retail limited partners.
- Ownership category
- akta.pro rank
MIG Capital industry classification
Industry- Product category
- Venture Capital Investment Management
- NAICS
- Other Financial Vehicles (52599), Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where MIG Capital is headquartered
LocationHeadquarters
- HQ city
- München
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
MIG Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Management Fees: VC firms typically charge annual management fees on committed capital from their fund investors (limited partners).
- Carried Interest: MIG Capital generates returns through carried interest (performance fees) when portfolio companies are exited at gains. Notable exits include BioNTech (distributed ~600M EUR total to investors), Siltectra (sold to Infineon), and Hemovent (sold to MicroPort).
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
MIG Capital product offering
Product offeringCore offering
MIG Capital is a Munich-based venture capital firm that invests early to mid-stage equity capital in Deep Tech and Life Sciences companies, primarily in German-speaking Europe and beyond. Through its MIG Fonds (18 publicly accessible retail VC funds), it provides ticket sizes of EUR 1-10M (sweet spot EUR 3-5M) from seed through Series A, along with active portfolio support, strategic guidance, and international network access. The firm also earns carried interest from successful portfolio exits such as BioNTech, Siltectra, Hemovent, and others.
Product overview
MIG Capital is a Munich-based venture capital firm that invests in innovative Deep Tech and Life Sciences companies across Europe through its MIG Fonds (publicly accessible retail VC funds). MIG Capital does not develop or offer its own technology products or services; rather, it provides investment capital, expertise, and network access to portfolio companies developing innovations in biopharmaceuticals, quantum computing, AI hardware, digital health, medical devices, and sustainable technologies. The MIG Fonds are the firm's primary investment vehicle, offering retail investors access to early-stage venture capital investments with a focus on seed to Series B stages.
Differentiator
Problem solved
Functional benefit
Products and services
- MIG Fonds (Retail VC Funds) Publicly accessible retail venture capital funds (currently 18 MIG Fonds) that pool private investor capital for deployment into MIG Capital's portfolio of Deep Tech and Life Sciences companies. Managed by MIG Capital AG under German KAGB regulation with a designated depositary bank.
- Deep Tech Equity Investment Program Equity investment offering targeting early-stage startups in advanced computing (AI, quantum computing), industrial IoT, robotics, automation, sustainable energy, and novel materials. Typical ticket sizes EUR 1-10M with sweet spot EUR 3-5M from seed through Series A, with active portfolio support and international expansion network.
- Life Sciences Equity Investment Program Equity investment offering for biopharmaceutical, medical technology, and digital health startups. Investment focus covers oncology, autoimmune diseases, brain trauma, microbiome therapeutics, hearing technologies, and related fields. Ticket sizes EUR 1-10M with active portfolio support and pharmaceutical partnership network access.
Quantifiable outcome
- EUR 600 million distributed to investors from BioNTech exit alone
- +3 more outcomes
Companies that use MIG Capital
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles3 records
MIG Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MIG Capital partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Hauck Aufhäuser Lampe Privatbank AGcustodianDesignated depositary bank (Verwahrstelle) for MIG Capital's funds as required by German KAGB regulation.
Scale indicators10 records
Recent moves12 records
Expansion highlights4 records
MIG Capital competitors and assessment
Company assessmentMarket position
Weaknesses3 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
MIG Capital social profiles
Digital presenceMIG Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
MIG Capital leadership team
Management profileNumber of profiles
Profiles9 records
MIG Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MIG Capital M&A and investment
M&A and investmentM&A
Investments97 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MIG Capital
What does MIG Capital do?
MIG Capital is a Munich-based venture capital firm that invests early to mid-stage equity capital in Deep Tech and Life Sciences companies, primarily in German-speaking Europe and beyond. Through its MIG Fonds (18 publicly accessible retail VC funds), it provides ticket sizes of EUR 1-10M (sweet spot EUR 3-5M) from seed through Series A, along with active portfolio support, strategic guidance, and international network access. The firm also earns carried interest from successful portfolio exits such as BioNTech, Siltectra, Hemovent, and others.
Is MIG Capital a public or private company?
MIG Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MIG Capital founded?
MIG Capital was founded in 2004. It employs 11 to 50 people.
Where is MIG Capital based?
MIG Capital is headquartered in München, Germany, in the Europe region.
How does MIG Capital make money?
Two revenue lines are on record. Management Fees are the primary driver. The others are carried Interest.
Does MIG Capital have an API?
No public API is recorded for MIG Capital.
What industry is MIG Capital in?
MIG Capital's product category is Venture Capital Investment Management. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists). Its NAICS code is 52599 and its SIC code is 6282.